Back
Janus Henderson Small Cap Growth Alpha ETF Vs. Structure Therapeutics, Inc. Industry Stock Comparison
Buy
61
JSML
Janus Henderson Small Cap Growth Alpha ETF
Last Price:
$75.22
Seasonality Move:
1.03%
Buy
67
GPCR
Structure Therapeutics, Inc.
Last Price:
$66.67
Seasonality Move:
-31.39%
Buy
61
Janus Henderson Small Cap Growth Alpha ETF (JSML)
is a Buy
Is Janus Henderson Small Cap Growth Alpha ETF a Buy, Sell or Hold?
-
The current Janus Henderson Small Cap Growth Alpha ETF [JSML] share price is $74.65. The Score for JSML is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
-
JSML is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
67
Structure Therapeutics, Inc. (GPCR)
is a Buy
Is Structure Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Structure Therapeutics, Inc. [GPCR] share price is $69.98. The Score for GPCR is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
-
GPCR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
JSML Stock Price Chart
What is Janus Henderson Small Cap Growth Alpha ETF's stock price today?
-
The Janus Henderson Small Cap Growth Alpha ETF share price today is $74.65Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and JSML is experiencing selling pressure, which indicates risk of future bearish movement.
GPCR Stock Price Chart
What is Structure Therapeutics, Inc.'s stock price today?
-
The Structure Therapeutics, Inc. share price today is $69.98Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GPCR is experiencing slight buying pressure.
JSML Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.22 | Buy |
| Relative Strength Index (14 RSI): | 54.68 | Buy |
| Chaikin Money Flow: | -25529 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (71.72 - 74.92) | Buy |
| Bollinger Bands (100): | (70.09 - 75.43) | Buy |
GPCR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.48 | Buy |
| Relative Strength Index (14 RSI): | 86.01 | Buy |
| Chaikin Money Flow: | 124529 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (28.63 - 42.89) | Buy |
| Bollinger Bands (100): | (18.11 - 33.75) | Buy |
JSML Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 74.31 | Buy |
| 20-day SMA: | 73.18 | Buy |
| 50-day SMA: | 74.1 | Buy |
| 200-day SMA: | 67.81 | Buy |
| 8-day EMA: | 74.12 | Buy |
| 20-day EMA: | 73.69 | Buy |
| 50-day EMA: | 71.89 | Buy |
| 200-day EMA: | 44.18 | Buy |
GPCR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 38.22 | Buy |
| 20-day SMA: | 36.44 | Buy |
| 50-day SMA: | 32.1 | Buy |
| 200-day SMA: | 23.71 | Buy |
| 8-day EMA: | 41.78 | Buy |
| 20-day EMA: | 37.11 | Buy |
| 50-day EMA: | 32.59 | Buy |
| 200-day EMA: | 27.3 | Buy |
Janus Henderson Small Cap Growth Alpha ETF Earnings Growth & JSML Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Structure Therapeutics, Inc. Earnings Growth & GPCR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.49 per share, and a decrease next year of $0.15 per share.
Janus Henderson Small Cap Growth Alpha ETF Technical Analysis
| Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | 05 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Structure Therapeutics, Inc. Technical Analysis
| Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | 05 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||